$HSTC
HST Global Inc

2018 Q3 Form 10-Q Financial Statement

#000167479618000049 Filed on November 02, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2017 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $34.64K $30.00K
YoY Change 15.47% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $34.64K $30.00K
YoY Change 15.47% 0.0%
Operating Profit -$34.64K -$30.00K
YoY Change 15.46% -10.57%
Interest Expense -$8.940K -$10.00K
YoY Change -10.6% 0.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $20.00K
YoY Change -100.0% -323.79%
Pretax Income -$43.58K -$20.00K
YoY Change 117.9% -50.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$43.58K -$20.00K
YoY Change 117.9% -50.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$17.80K -$8.163K
COMMON SHARES
Basic Shares Outstanding 36.72M shares 36.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $510.6K $510.0K
YoY Change 0.13% -3.77%
Accrued Expenses $1.448M $1.290M
YoY Change 12.22% 13.16%
Deferred Revenue
YoY Change
Short-Term Debt $1.369M $1.340M
YoY Change 2.17% 1.52%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.327M $3.150M
YoY Change 5.63% 5.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.327M $3.150M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.327M $3.150M
YoY Change 5.63% 5.7%
SHAREHOLDERS EQUITY
Retained Earnings -$5.749M -$5.571M
YoY Change 3.2% 3.06%
Common Stock $36.72K $36.72K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.327M -$3.150M
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$43.58K -$20.00K
YoY Change 117.9% -50.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$6.590K -$10.00K
YoY Change -34.1% 0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.300K 10.00K
YoY Change -37.0% 0.0%
NET CHANGE
Cash From Operating Activities -6.590K -10.00K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 6.300K 10.00K
Net Change In Cash -290.0 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$6.590K -$10.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address City Or Town
EntityAddressCityOrTown
Hampton
dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23666
dei City Area Code
CityAreaCode
757
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Entity File Number
EntityFileNumber
000-15303
dei Entity Registrant Name
EntityRegistrantName
HST GLOBAL, INC.
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Nevada
dei Entity Address Address Line1
EntityAddressAddressLine1
150 Research Drive
dei Trading Symbol
TradingSymbol
HSTC
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
731215433
CY2017Q2 dei Entity Public Float
EntityPublicFloat
100000 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Local Phone Number
LocalPhoneNumber
766-6100
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36719854 shares
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291 usd
CY2018Q3 us-gaap Assets Current
AssetsCurrent
0 usd
CY2017Q4 us-gaap Assets Current
AssetsCurrent
291 usd
CY2018Q3 us-gaap Assets
Assets
0 usd
CY2017Q4 us-gaap Assets
Assets
291 usd
CY2018Q3 us-gaap Bank Overdrafts
BankOverdrafts
1387 usd
CY2017Q4 us-gaap Bank Overdrafts
BankOverdrafts
0 usd
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4681 usd
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4688 usd
CY2018Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
505959 usd
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36719854 shares
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
36720 usd
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
36720 usd
CY2017Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
505959 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
90000 usd
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4638 usd
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36719854 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36719854 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36719854 shares
CY2018Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
1080000 usd
CY2017Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
990000 usd
CY2018Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
367692 usd
CY2017Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
340881 usd
CY2018Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1367669 usd
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1351369 usd
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3327388 usd
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3192897 usd
CY2018Q3 us-gaap Liabilities
Liabilities
3327388 usd
CY2017Q4 us-gaap Liabilities
Liabilities
3192897 usd
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2384824 usd
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2384824 usd
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5748932 usd
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5614151 usd
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-3327388 usd
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-3192607 usd
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
291 usd
CY2018Q3 us-gaap Revenues
Revenues
0 usd
CY2017Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2018Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30000 usd
CY2017Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
90000 usd
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1112 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17970 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28718 usd
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
34638 usd
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
31112 usd
us-gaap Operating Expenses
OperatingExpenses
107970 usd
us-gaap Operating Expenses
OperatingExpenses
118718 usd
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-34638 usd
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-31112 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-107970 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-118718 usd
CY2018Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2017Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23651 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
23651 usd
CY2018Q3 us-gaap Interest Expense
InterestExpense
-8937 usd
CY2017Q3 us-gaap Interest Expense
InterestExpense
-8937 usd
us-gaap Interest Expense
InterestExpense
-26811 usd
us-gaap Interest Expense
InterestExpense
-26811 usd
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8937 usd
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14714 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26811 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3160 usd
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43575 usd
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16398 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-134781 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-121878 usd
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-43575 usd
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-16398 usd
us-gaap Net Income Loss
NetIncomeLoss
-134781 usd
us-gaap Net Income Loss
NetIncomeLoss
-121878 usd
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2017Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36719854 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36719854 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36719854 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
36719854 shares
us-gaap Profit Loss
ProfitLoss
-134781 usd
us-gaap Profit Loss
ProfitLoss
-121878 usd
fil Gain On Forgiveness Of Accounts Payable
GainOnForgivenessOfAccountsPayable
0 usd
fil Gain On Forgiveness Of Accounts Payable
GainOnForgivenessOfAccountsPayable
-23651 usd
fil Bank Overdraft Payable
BankOverdraftPayable
1387 usd
fil Bank Overdraft Payable
BankOverdraftPayable
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5889 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
90000 usd
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
90000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
26811 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
26811 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16591 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22829 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
16300 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
22700 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22700 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-291 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-129 usd
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
291 usd
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
465 usd
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0 usd
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
366 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16300 usd
CY2018Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1367669 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt"><span style="font-size:10pt"><b>NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES </b></span></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-align:justify">HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition has been accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia.</p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;text-align:justify">HST Global, Inc. is an integrated Health and Wellness Biotechnology company that is developing and/or acquiring a network of Wellness Centers worldwide with the primary focus on homeopathic and alternative treatments of late stage cancer and other life threatening diseases.  In addition, the Company intends to acquire innovative products for the treatment of life threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed significant clinical testing for the treatment of late stage cancer and/or life threatening diseases.</p>
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000"><span style="border-bottom:1px solid #000000">Basis of Presentation</span></p> <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify">The accompanying financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the United States Securities and Exchange Commission (“SEC”) to Form 10-K.  </p>
us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the <p style="font:10pt Times New Roman;margin-top:0pt;margin-bottom:12pt;color:#000000;text-align:justify"><span style="font:10pt Times New Roman">reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2017Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1351369 usd
CY2018Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4500 usd

Files In Submission

Name View Source Status
0001674796-18-000049-index-headers.html Edgar Link pending
0001674796-18-000049-index.html Edgar Link pending
0001674796-18-000049.txt Edgar Link pending
0001674796-18-000049-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hstc-20180930.htm Edgar Link pending
hstc-20180930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hstc-20180930_def.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hstc-20180930_lab.xml Edgar Link unprocessable
hstc-20180930_htm.xml Edgar Link completed
hstc-20180930_pre.xml Edgar Link unprocessable
hstc-20180930_cal.xml Edgar Link unprocessable